341 related articles for article (PubMed ID: 18500823)
1. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
Spensberger D; Vermeulen M; Le Guezennec X; Beekman R; van Hoven A; Bindels E; Stunnenberg H; Delwel R
Biochemistry; 2008 Jun; 47(24):6418-26. PubMed ID: 18500823
[TBL] [Abstract][Full Text] [Related]
2. EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression.
Cattaneo F; Nucifora G
J Cell Biochem; 2008 Oct; 105(2):344-52. PubMed ID: 18655152
[TBL] [Abstract][Full Text] [Related]
3. A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a.
Spensberger D; Delwel R
FEBS Lett; 2008 Aug; 582(18):2761-7. PubMed ID: 18619962
[TBL] [Abstract][Full Text] [Related]
4. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation.
Wade PA; Gegonne A; Jones PL; Ballestar E; Aubry F; Wolffe AP
Nat Genet; 1999 Sep; 23(1):62-6. PubMed ID: 10471500
[TBL] [Abstract][Full Text] [Related]
5. UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation.
McGilvray R; Walker M; Bartholomew C
FEBS J; 2007 Aug; 274(15):3960-71. PubMed ID: 17635584
[TBL] [Abstract][Full Text] [Related]
6. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression.
Suzuki M; Yamada T; Kihara-Negishi F; Sakurai T; Oikawa T
Oncogene; 2003 Nov; 22(54):8688-98. PubMed ID: 14647463
[TBL] [Abstract][Full Text] [Related]
7. The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells.
Senyuk V; Chakraborty S; Mikhail FM; Zhao R; Chi Y; Nucifora G
Oncogene; 2002 May; 21(20):3232-40. PubMed ID: 12082639
[TBL] [Abstract][Full Text] [Related]
8. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.
Cismasiu VB; Adamo K; Gecewicz J; Duque J; Lin Q; Avram D
Oncogene; 2005 Oct; 24(45):6753-64. PubMed ID: 16091750
[TBL] [Abstract][Full Text] [Related]
9. Developmental roles of the Mi-2/NURD-associated protein p66 in Drosophila.
Kon C; Cadigan KM; da Silva SL; Nusse R
Genetics; 2005 Apr; 169(4):2087-100. PubMed ID: 15695365
[TBL] [Abstract][Full Text] [Related]
10. The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes.
Feng Q; Zhang Y
Genes Dev; 2001 Apr; 15(7):827-32. PubMed ID: 11297506
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
12. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
Wu Y; Zhang X; Salmon M; Zehner ZE
Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
[TBL] [Abstract][Full Text] [Related]
13. Methyl CpG-binding proteins and transcriptional repression.
Wade PA
Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
[TBL] [Abstract][Full Text] [Related]
14. Deacetylation of p53 modulates its effect on cell growth and apoptosis.
Luo J; Su F; Chen D; Shiloh A; Gu W
Nature; 2000 Nov; 408(6810):377-81. PubMed ID: 11099047
[TBL] [Abstract][Full Text] [Related]
15. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation.
Fujita N; Jaye DL; Geigerman C; Akyildiz A; Mooney MR; Boss JM; Wade PA
Cell; 2004 Oct; 119(1):75-86. PubMed ID: 15454082
[TBL] [Abstract][Full Text] [Related]
16. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
[TBL] [Abstract][Full Text] [Related]
17. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation.
Criqui-Filipe P; Ducret C; Maira SM; Wasylyk B
EMBO J; 1999 Jun; 18(12):3392-403. PubMed ID: 10369679
[TBL] [Abstract][Full Text] [Related]
18. The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation.
Choi WI; Jeon BN; Yoon JH; Koh DI; Kim MH; Yu MY; Lee KM; Kim Y; Kim K; Hur SS; Lee CE; Kim KS; Hur MW
Nucleic Acids Res; 2013 Jul; 41(13):6403-20. PubMed ID: 23658227
[TBL] [Abstract][Full Text] [Related]
19. MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.
Jiang CL; Jin SG; Pfeifer GP
J Biol Chem; 2004 Dec; 279(50):52456-64. PubMed ID: 15456747
[TBL] [Abstract][Full Text] [Related]
20. Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts.
Gozzini A; Rovida E; Dello Sbarba P; Galimberti S; Santini V
Cancer Res; 2003 Dec; 63(24):8955-61. PubMed ID: 14695213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
